Conditions: Esophageal Cancer
Intervention Type: Biological
Intervention Name: LMB-9 immunotoxin
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Biological" intervention "LMB-9 immunotoxin" on "Esophageal Cancer".
-
Phase I Study of LMB-9, a Recombinant Disulfide Stabilized Immunotoxin for Advanced Carcinomas That Express Lewis Y Antigen
NCTID: NCT00019435
-
A Phase I Study Of LMB-9, A Recombinant Disulfide Stabilized Anti-Lewis Y Immonutoxin Administered By 5-Days Continuous Infusion For Patients With Colorectal Adenocarcinoma
NCTID: NCT00010270